MS Research Australia has welcomed the Federal Government’s re-commitment to the $20 billion Medical Research Future Fund (MRFF)

In a media release issued on 1 December, pharmaceutical company Novartis, the makers of Gilenya (fingolimod), have announced

Imagine a cat’s cradle – a network of threads running to and fro, crossing over and diverging again

MS Research Australia is proud to have nominated four very inspiring individuals for prestigious awards which recognisetheir tireless

As part of our ten year anniversary, MS Research Australia has taken a detailed look at all research

2014 marks the tenth anniversary of MS Research Australia and a decade of accelerating, enabling and funding Australian

Researchers from the University of Sydney and the Kid’s Research Institute at The Children’s Hospital Westmead are making

The 2014 annual meeting of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) was held

The role of stress in MS has been debated for decades. While some studies have suggested a link